We report a case of a 9-year-old boy diagnosed with aneurysmal bone cyst (ABC) of
C5 to D1 vertebral levels and scheduled for re-exploration and tumour excision under
general anaesthesia. He was apparently healthy 5 years back when he developed progressive
weakness of both lower limbs and a sense of incomplete evacuation of bladder. He was
operated for the tumour excision along with rod placement and pedicle screw fixation
without any complications. He was re-explored 2 years later for the recurrence of
ABC. For the past 2 months, he had been complaining of pain at the surgical site associated
with decrease in the motor power in the upper and lower limbs. Magnetic resonance
imaging (MRI) revealed residual ABC causing cervico-dorsal canal stenosis with cord
changes between C6 to D2 vertebral levels. Routine blood investigations were within
normal limits.
General anaesthesia was induced with fentanyl 80 mcg, propofo l70 mg and rocuronium
40 mg. Besides routine monitoring, invasive monitoring (arterial and central venous
cannulation) was performed. Owing to multiple surgeries in the past, adhesions and
fibrosis were present at the surgical site, resulting in excessive oozing of blood.
Surgeons applied fibrin sealant (TISSEELTM KIT) to achieve haemostasis. Immediately the patient had sudden hypotension (blood
pressure decreased from 110/70 to 50/22 mmHg), without any change in the heart rate
[Figure 1]. The plethysmography curve also disappeared, possibly because of low peripheral
perfusion. The surgeons were informed immediately. Fluid resuscitation was done with
crystalloid (500 ml) and colloid (500 ml). Mephenteramine 6 mg was administered along
with hydrocortisone 100 mg. Blood pressure increased to 110/64 mmHg in the next few
minutes and surgery was resumed. The rest of the intraoperative and postoperative
courses were unremarkable.
Figure 1: Graph showing sudden fall in Arterial blood pressure. Upper white line- systolic
blood pressure green line- mean arterial blood pressure lower white line- diastolic
blood pressure
In our case, there remains a possibility of hypersensitivity reaction to fibrin sealant
in paediatric patient undergoing spine surgery in prone position. It is likely that
the hypersensitivity to fibrin glue resulted in sudden haemodynamic instability. Fibrin
sealants (fibrin glue/fibrin adhesive) are the plasma-derived products, which mimic
the final stage of clotting pathway resulting in the conversion of fibrinogen to fibrin.
These products have haemostatic properties and act independent of patients’ clotting
mechanism in the body. These products are either homologous or autologous in origin.[1] They are used to achieve haemostasis to seal tissue and to support wound healing.[2] However, the use of these products is not free from complications. Severe and fatal
incidents of anaphylactic reactions and thromboembolism have been reported in literature.[3]
[4]
[5] The incidence of hypersensitivity reactions is extremely rare, ranging from 0.5
per 100,000 cases for all reactions to 0.3 per 100,000 cases for serious reactions.[6] The serologic screening includes qualitative and quantitative estimation of aprotinin
specific IgE and IgG antibodies.[7]
[8]
[9] Fibrin sealants contain human protein concentrate (fibrinogen, plasminogen and factor
XIII), thrombin, aprotinin and calcium chloride. It is contraindicated in individuals
with a known hypersensitivity to aprotinin. In few cases, these reactions have also
progressed to severe anaphylaxis.[4]
[5]
[6] Such reactions are seen when fibrin sealants are applied repeatedly over time or
in the same sitting. Koberand colleagues reported anaphylactic reaction due to systemic
administration of aprotinin where it was used for coronary artery bypass graft surgery.[10] In another case, mortality was reported because of the application offibrin glue
on adural tear.[11] Here, it is important to state that even if the first contactis well tolerated,
it does not exclude the occurrence of an immediate or a delayed allergic reaction.[7]
[8] The signs and symptoms include bradycardia, tachycardia, hypotension, flushing,
bronchospasm, wheezing, dyspnoea, nausea, urticaria, angioedema, pruritus, erythema
and paraesthesia. Mild reactions can be managed with antihistaminic, steroids and
adrenaline. The serologic screening includes qualitative and quantitative estimation
of aprotinin-specific IgE and IgG antibodies, skin prick tests for bovine aprotinin
and drug-induced lymphocyte stimulation test.[7]
[8]
[9] However, in the postoperative period, we did not investigate our patient for antibodies
specific for aprotinin, as the patient refused to give consent for further investigations.
Incidence of embolism hasalso been reported with fibrin glue, hence it should not
be injected directly into the circulatory system.[4] To avoid adverse life-threatening anaphylactic reactions, any treatment with aprotinin
during the previous 12 months should be considered as a contraindication, as recommended
in the Food and Drug Administration guidelines.[12]
Our case is a reminder of a possible hypersensitivity reaction with use of fibrin
sealants. As we have discussed above, the hypersensitivity reaction could range from
mild reaction to mortality. Hence, it should be used very cautiously and judiciously
in neurosurgical practise.
